Skip to content
10-K/A

Annual Report

CATALYST PHARMACEUTICALS, INC. CPRX

0001193125-26-197490

← back to feed
Filed
Apr 30, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 27, 2026 122.35M sh
Net Income FY 2025 · Dec 31, 2025 $214.33M
Net Income FY 2025 · Dec 31, 2024 $163.89M
Net Income FY 2025 · Dec 31, 2023 $71.41M